Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans
- 1 October 1989
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 17 (10), 975-978
- https://doi.org/10.1097/00003246-198910000-00001
Abstract
In a study of serum levels of tumor necrosis factor (TNFα) and interleukin-1β (IL-1β) in patients developing sepsis in the ICU, high TNFα levels were found in patients with septic shock. Normal values are 75 ± 15 pg/ml; in these patients, TNFα serum level ranged from 100 to 5000 pg/ml with a mean of 701 ± 339 pg/ ml and a median of 250 pg/ml. There was a correlation between TNFα level and sepsis severity score as well as with mortality. In contrast, IL-1β serum levels were only slightly increased and were not correlated with severity or mortality. (Crit Care Med 1989; 17:975)This publication has 5 references indexed in Scilit:
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraNew England Journal of Medicine, 1988
- Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.The Journal of Experimental Medicine, 1987
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.The Journal of Experimental Medicine, 1985